Purpose : To examine the reproductive performance of hepatitis B (HBV) and C (HCV) discordant couples following IVF-ET. Methods : A retrospective cohort study of 25 IVF-ET cycles in HBV and HCV discordant couples was performed. Thirteen patients in the study cohort were discordant for HBV (10 males and 3 females), and 12 (9 males and 3 females) for HCV. Twenty-seven consecutive age matched patients comprised the control group. All patients underwent controlled ovarian hyperstimulation using the long downregulation protocol followed by IVF or ICSI. Results : Patients in the three groups (HBV, HCV, and controls) had similar ages, and day 3 FSH concentrations. Despite comparable response to COH, and similar fertilization, and cleavage rates in the three groups, couples discordant for HBV or HCV had significantly poorer implantation and pregnancy rates (7.7%, 0% respectively) compared with controls (41%). Conclusions : Despite comparable response to COH, HBV and HCV positive discordant couples, have significantly lower implantation and pregnancy rates compared with age-matched controls.
INTRODUCTION
Hepatitis B (HBV) and C (HBC) are among the most common serious viral infections in humans. It is estimated that more than two billion people worldwide have been exposed to the HBV virus (1) . In the USA, 4.9 and 1.8% of the population are believed to be infected with HBV and HCV, with approximately 80,000 and 35,000 new infections being reported each year respectively (2) .
Except in acute cases or exacerbations of the disease, pregnancy is not contraindicated in subjects with HBV or HCV infections. Pregnancy does not appear to influence the course of the disease nor does the disease have an adverse effect on pregnancy outcome (3) . Given the acceptability of a spontaneous pregnancy in patients chronically infected with HBV or HCV, there is no ethically sound reason for declining IVF treatment in these patients (4) . Knowledge of the serostatus of the couple however, allows firstly for immunoprophylactic measures to be taken to reduce the risk of transmission to the partner, fetus, or newborn baby, and secondly, for precautions to be taken against cross-contamination during sample handing and embryo cryostorage. Furthermore, it enables couples to make an informed decision regarding pursuance of treatment (5) . For the welfare of any child born as a result of ART in mind, the European Society of Human Reproduction and Embryology (ESHRE) recommends the screening of both the partners for HBV and HCV prior to commencing treatment (6) .
In case of HBV affecting the male, the female partner can be immunized, thereby reducing the risk of transmission. Although HCV viral RNA has been detected in the semen, the role of sexual, perinatal, and other possible nonparenteral routes of HCV transmission is still unclear (7) (8) (9) , but from the available evidence this risk appears to be minimal (10) . Indeed, even in the presence of acute infection, semen viremia is extremely low as evaluated by PCR (11) (12) (13) (14) , suggesting a low risk of sexual transmission. Thus IVF is not contraindicated in these couples (15, 16) . Moreover, the value of routine detection of HCV viral RNA in seminal fluid and culture medium is questionable (17) , and the results must be interpreted with caution, as seminal amplification inhibitors may render the results of PCR unreliable (11, 18) . Notwithstanding the possibility of sexual transmission, a recent report has drawn attention to the possibility of nosocomial transmission of HCV during ancillary procedures for ART (19) , indicating the need for exercising special precaution in specimen handing in the embryology laboratory.
Given the paucity of available data on the reproductive performance of couple testing seropositive to HBV and HCV on initial screening, we undertook the present study to examine the IVF performance of serodiscordant couples. We wished to investigate the response to COH, fertilization rates, cleavage rates as well as embryo quality in these patients. Implantation and pregnancy rates were secondary study end points. (20) . Human chorionic gonadotropin (hCG) (Profasi ® , Serono Canada Ltd), 10,000 IU was administered subcutaneously when at least three follicles ≥18 mm in diameter were observed. Oocyte retrieval was performed 36 h after hCG administration by transvaginal ultrasonography guided needle aspiration under intravenous sedation. After retrieval, oocytes were collected into Vitrolife ® IVF media (Vitrolife, Goteberg, Sweden) and fertilized by conventional insemination or ICSI depending on whether there was severe male factor infertility. Fertilization was confirmed 16-18 h after insemination by the presence of two pronuclei; embryo assessment was made as previously described (21) and embryo transfer was performed on day 2/3 or 5/6 depending on the number and quality of the embryos available (22) . The number of embryos transferred depended on the age and history of the individual patient, but generally patients less than 35 years of age received two embryos, up to 39 years of age received three embryos and patients over 40 years of age received four embryos. Progesterone (50 mg/day IM) in oil was used for luteal support. The same protocol was followed for both groups of patients. Hepatitis positive patients' embryos were cultured in a separate incubator and the semen was processed in a separate centrifuge to minimize the risk of cross-contamination. Pregnancy was diagnosed by serum βhCG estimation 14 days after embryo transfer. Clinical pregnancy was confirmed by transvaginal ultrasound examination 4 weeks after the positive pregnancy test.
MATERIALS AND METHODS

All
The data were not normally distributed, and MannWhitney U test was used to test the null hypothesis of there being no significant difference between the control and the hepatitis groups. Chi-square test was used to study the difference in proportions between the groups. The data for HBV and HCV groups were analyzed separately and together. Given that the results in both groups were broadly similar, the results are presented collectively in the text.
RESULTS
Twenty-five patients comprised the study cohort. Thirteen subjects tested positive for HBV; in 10 patients the male partner was affected, and in 3 the female partner was affected. Twelve patients were seropositive for HCV. In nine subjects, the male partner was affected, while in three the female tested positive for the virus. All patients tested negative for HIV, and had undergone a detailed assessment of their liver function by the hepatologist prior to commencing IVF treatment. Most patients (10/12) in the HCV group had biochemical evidence of mild chronic hepatitis, but none had moderate or severe chronic hepatitis. No patient had received antiviral treatment prior to commencing the IVF cycle. Patients were matched by diagnoses, and there were no differences in the causes of infertility in the two groups. The semen analysis was not significantly different between the two hepatitis groups and between the hepatitis group and controls.
The data in each of the groups were analyzed together and separately. There were no significant difference in age and basal FSH concentrations between the two hepatitis groups and controls (Table I) . The response to COH was similar in all groups as shown by total gonadotropin dosage requirement, the maximal E 2 on day of hCG, and the number of oocytes retireved. In the control group 22 patients had IVF, while 5 patients had ICSI. In the hepatitis group as a whole, 17 patients had IVF, 5 had ICSI, while 3 patients had rescue ICSI following failed fertilization. The fertilization and cleavage rates and the number of embros transferred were similar in both hepatitis groups and between the hepatitis group and controls. In the control group 11 clinical pregnancies were observed on ultrasound scan; in 7 patients a single gestation sac was seen, while 4 patients had multiple pregnancies and 1 patient had a triplet pregnancy. One pregnancy was recorded in the HBV group where a single gestation sac was observed on ultrasound scan. These differences in pregnancy rates were highly significant (χ 2 = 7.52; p = 0.0061).
DISCUSSION
To the best of our knowledge, this is the first study that has examined the reproductive performance of patients discordant for HBV and HCV following IVF treatment. The results of this study suggest that these patients have suboptimal outcomes with regard to pregnancy and implantation rates when compared with age and diagnosis matched controls. To the extent that our conclusions are on the basis of a small number of patients, the results of the present study should be considered preliminary. The reasons for the disparate pregnancy rates between groups are not immediately obvious. It is possible that the results could be attributable to the small sample size and to type 1 error. However, given the significant difference in pregnancy rates in the two groups, retrospective power analysis reveals that the present study had a 91.5% power to detect a significant difference between the two groups with 5% alpha.
Despite the demonstration of low risk of cross contamination and of nosocomial transmission during IVF or ICSI techniques from HCV+ couples (17, 19) , the possibility for transmission merits special precautions in handing potentially infective material in the laboratory. This includes handling the samples separately in the laboratory from other HCV-couples, and using separate incubators for embryo culture. It is possible that these extra precautions and handling techniques could have contributed to the dissimilar results observed in implantation and pregnancy rates between hepatitis groups and controls. Notably though, all the hepatitis samples were handled in exactly the same way and by the same personnel as control subjects, and the same incubator was used for embryo culture that is routinely used in all our IVF and ICSI cases. Furthermore the cleaning procedure and the techniques for handling all the specimens were similar in both groups of patients (3) .
The reverse transcriptase activity of the HBV viral DNA polymerase may explain the integration of HBV DNA in the spermatozoa at least during the acute phase of HBV infection (16) . Although this raises the question of vertical transmission of HBV infection, its effect on semen parameters, particularly on sperm motility has not been examined. There is also no published evidence of the effect of chronic infection or of past infection on semen parameters. Thus the explanation for the poor implantation and pregnancy rates observed in this group of patients is not self evident. In contrast, HCV being a RNA virus lacks reverse transcriptase activity, making it is impossible for the viral RNA to integrate into the genome of the host (16) . Although it is unlikely that sperm supports HCV replication, it has been suggested that it may interfere with sperm motility by passive adsorption to the cell membrane (23) . Interestingly, in the present study, although the semen parameters were similar in controls and hepatitis patients, the three cases of failed fertilization occurred in the hepatitis group (two in the HBV group and one in the HBC patient), suggesting that impaired sperm binding in these patients may, in part be responsible for the poor results observed. It is also possible that viral infections per se may impair fertility by immunological, inflammatory, or direct toxic effects on spermatogenesis (24) . It is tempting to speculate that these effects on sperm function may have contributed to the poor results observed in the HCV-positive group of patients. Indeed, results of one small study demonstrated the benefit of ICSI over IVF in HCV positive patients (17) . It is possible that sperm washing may reduce the HCV viral load prior to insemination or ICSI (14) and may have a favorable effect on pregnancy rates in HCV+ subjects. This needs to be explored in the context of a larger prospective study. In contrast to the findings of the current study, in the only other published study that examined the percentage of apoptotic granulosa cells in six HCV+ and six HCV− controls (25) demonstrated no difference in pregnancy rates in the two groups of patients. However, neither ovarian response nor IVF outcomes were the end points of this study.
CONCLUSION
In conclusion, the present study has demonstrated a poor reproductive outcome in HBV and HCV patients undergoing ART. Despite the methodological shortcomings, the results indicate that these subjects have suboptimal pregnancy rates compared to age matched control subjects. This should be investigated in a larger prospective study.
